Pulike Biological Engineering, Inc. (SHA:603566)
China
· Delayed Price · Currency is CNY 14.28
+0.09 (0.63%)
Jul 15, 2025, 1:44 PM CST
SHA:603566 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 118.41 | 92.81 | 174.52 | 167.82 | 244.14 | 227.74 | Upgrade
|
Depreciation & Amortization | 120.18 | 120.18 | 92.73 | 74.84 | 59.46 | 51.05 | Upgrade
|
Other Amortization | 2.11 | 2.11 | 0.53 | 0.48 | - | 0.16 | Upgrade
|
Loss (Gain) From Sale of Assets | 11.35 | 11.35 | 0.41 | 0.21 | 0.71 | 0.68 | Upgrade
|
Asset Writedown & Restructuring Costs | 1.93 | 1.93 | 0.23 | 0.33 | 2.63 | 0.05 | Upgrade
|
Loss (Gain) From Sale of Investments | 8.31 | 8.31 | 0.03 | 19.93 | -20.39 | -35.7 | Upgrade
|
Provision & Write-off of Bad Debts | -5.27 | -5.27 | 27.66 | 15.33 | 8.24 | 9.12 | Upgrade
|
Other Operating Activities | 26.18 | 0.5 | -3.11 | 4.91 | 0.22 | 0.02 | Upgrade
|
Change in Accounts Receivable | 88.95 | 88.95 | -6.43 | -219.23 | -102.27 | -57.07 | Upgrade
|
Change in Inventory | -9.99 | -9.99 | 7.89 | -19.67 | -36.75 | -15.76 | Upgrade
|
Change in Accounts Payable | -40.06 | -40.06 | -16.43 | 198.59 | 44.3 | 77.86 | Upgrade
|
Change in Other Net Operating Assets | 0.93 | 0.93 | 5.06 | -5.95 | 9.06 | -0.19 | Upgrade
|
Operating Cash Flow | 320.08 | 268.79 | 282.78 | 228.36 | 212.53 | 261.83 | Upgrade
|
Operating Cash Flow Growth | 30.00% | -4.95% | 23.83% | 7.45% | -18.83% | 86.89% | Upgrade
|
Capital Expenditures | -72.63 | -121.06 | -304.98 | -357.16 | -317.54 | -177.14 | Upgrade
|
Sale of Property, Plant & Equipment | 2.22 | 2.22 | 0.43 | 0.45 | 1.07 | 0.92 | Upgrade
|
Cash Acquisitions | - | - | -23.14 | - | - | - | Upgrade
|
Investment in Securities | -46.14 | -78.78 | 299.6 | -625.75 | 177.6 | 52.71 | Upgrade
|
Other Investing Activities | -0.5 | 9.35 | 26.43 | 27.27 | 8.36 | 15.77 | Upgrade
|
Investing Cash Flow | -117.06 | -188.26 | -1.66 | -955.19 | -130.51 | -107.74 | Upgrade
|
Short-Term Debt Issued | - | - | - | 37 | - | - | Upgrade
|
Total Debt Issued | - | - | - | 37 | - | - | Upgrade
|
Short-Term Debt Repaid | - | - | -7 | -30 | - | - | Upgrade
|
Long-Term Debt Repaid | - | -0.88 | -0.71 | - | - | - | Upgrade
|
Total Debt Repaid | -0.88 | -0.88 | -7.71 | -30 | - | - | Upgrade
|
Net Debt Issued (Repaid) | -0.88 | -0.88 | -7.71 | 7 | - | - | Upgrade
|
Issuance of Common Stock | - | - | - | 892.42 | - | - | Upgrade
|
Repurchase of Common Stock | -52.7 | -52.7 | -7.64 | - | - | -133.55 | Upgrade
|
Common Dividends Paid | -137.85 | -137.85 | -225 | -63.65 | -157.32 | -63.18 | Upgrade
|
Other Financing Activities | 17.63 | -0.14 | -0.67 | -3.03 | -0.25 | - | Upgrade
|
Financing Cash Flow | -173.79 | -191.56 | -241.03 | 832.74 | -157.57 | -196.73 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.04 | 0.01 | 0.31 | 0.34 | -0.22 | -0 | Upgrade
|
Net Cash Flow | 29.2 | -111.02 | 40.4 | 106.25 | -75.76 | -42.64 | Upgrade
|
Free Cash Flow | 247.44 | 147.73 | -22.2 | -128.8 | -105.01 | 84.69 | Upgrade
|
Free Cash Flow Growth | 7014.14% | - | - | - | - | 54.19% | Upgrade
|
Free Cash Flow Margin | 22.79% | 14.17% | -1.77% | -10.47% | -9.56% | 9.12% | Upgrade
|
Free Cash Flow Per Share | 0.73 | 0.43 | -0.06 | -0.40 | -0.34 | 0.27 | Upgrade
|
Cash Income Tax Paid | 66.91 | 68.11 | 101.94 | 62.05 | 79.92 | 71.04 | Upgrade
|
Levered Free Cash Flow | 167.9 | 95.89 | -121.29 | -190.31 | -192.46 | -7.9 | Upgrade
|
Unlevered Free Cash Flow | 167.95 | 95.95 | -120.71 | -189.77 | -192.46 | -7.9 | Upgrade
|
Change in Net Working Capital | -33.01 | -28.52 | 15.8 | 17.85 | 73.2 | -11.76 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.